Huma Qamar
Chief Tech/Sci/R&D Officer chez OCUGEN, INC.
Fortune : 2 695 $ au 31/03/2024
Profil
Huma Qamar is currently the Chief Medical Officer at Ocugen, Inc. since 2024.
She is also currently serving as the Chief Scientific Officer at Medicus Pharma Ltd.
since 2023.
Previously, she worked as the Head of Research & Development at FSD Pharma, Inc. Dr. Qamar obtained her doctorate degree from Army Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUGEN INC
0,00% | 16/04/2024 | 1 643 ( 0,00% ) | 2 695 $ | 31/03/2024 |
Postes actifs de Huma Qamar
| Sociétés | Poste | Début |
|---|---|---|
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 18/03/2024 |
Anciens postes connus de Huma Qamar
| Sociétés | Poste | Fin |
|---|---|---|
| FSD PHARMA INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Huma Qamar
| Army Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FSD PHARMA INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Ocugen, Inc. |
